Raphael Teipel

5PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRegenerative medicine (incl. stem cells)Medical devicesTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 12, 2026
Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Feb 13, 2026
Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy.

Jan H Frenking, Christine Riedhammer, Thomas Hielscher

|Feb 25, 2025
Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies?

Simone Karp, Karolin Trautmann-Grill, Paul Warncke

|Mar 12, 2024
Successful treatment of scleromyxoedema with daratumumab.

Katharina Epp, Raphael Teipel, Ulrike Reuner

|Mar 13, 2018
Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial.

Johannes Schetelig, Cornelia S Link, Gernot Stuhler

Pageof 1

Frequent Collaborators

1 joint publications

Johannes Schetelig

1 joint publications

Katharina Epp

1 joint publications

Mathias Hänel

1 joint publications

Jan H Frenking